January 19, 2016 at EndGames Improv in San Francisco.
THIS WEEK’S SPECIAL GUEST:
Matt Sander, Biomedical Engineer & Senior Scientist
TOPIC: “Diabetes 101″
Unquenchable thirst. Blurred vision. Extreme fatigue. These are a few symptoms of diabetes, a disease that one in four people don’t now they have and effects nearly 30 million Americans. That’s roughly 10% of US adults. Even more shocking is that 86 million US adults – more than a third of the population– have prediabetes. So what are we doing about this disease and what do you need to know?
Biomedical engineer and senior scientist Matt Sander has spent his career developing innovative healthcare solutions and is at the forefront of transforming the treatment of diabetes. Learn about the newest innovations including inhaled insulin, which will make taking daily shots of insulin a thing of the past.
Matt Sander is a biomedical engineer and senior scientist with Dance Biopharm, a company devoted to transforming the treatment of diabetes. Matt received a BA in biochemistry from UC Berkeley and an MS in biomedical engineering from UCSF, and has spent 10 years developing innovative healthcare treatments. He currently works in metabolic disease with the Dance Biopharm team, who are running late stage clinical trials for pulmonary (inhaled) insulin, a hormone that helps diabetics control their blood sugar.